Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Generalized peripheral lymphadenopathy in a patient treated for chronic HCV infection

Abstract

Background A 62-year-old white woman was admitted to hospital with a 2-month history of progressive, painless, left supraclavicular and axillary lymph node enlargement. The patient's history was significant for chronic HCV infection, for which she had just completed a 48-week course of treatment with pegylated interferon α (180 µg once weekly) plus ribavirin (1,000 mg daily). She attained an end-of-treatment response and subsequent qualitative measurement of HCV RNA confirmed a sustained virological response. The onset of progressive painless lymph node enlargement had been noted by the patient during the last 2 weeks of her treatment for HCV.

Investigations Physical examination, otorhinolaryngological examination, laboratory investigations (including complete blood counts, liver function tests and serological tests), mammography, thyroid and abdominal ultrasound, CT scans, abdominal MRI, upper gastrointestinal endoscopy, colonoscopy, supraclavicular lymph node biopsy, 67Ga scintigraphy and bronchoalveolar lavage.

Diagnosis Granulomatous lymphadenitis of uncertain etiology with sarcoid-type and tuberculoid-type granulomas.

Management Standard antituberculosis treatment with isoniazid, rifampicin, pyrazinamide and ethambutol for 2 months, followed by isoniazid and rifampicin for 7 months.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A thoracic CT scan of the case patient.
Figure 2: Histological features of a lymph node biopsy from the case patient.
Figure 3: Images obtained by a 67Ga scan of the case patient.

References

  1. Cervin JR et al. (1995) Virchow's node revisited. Analysis with clinicopathologic correlation of 152 fine-needle aspiration biopsies of supraclavicular lymph nodes. Arch Pathol Lab Med 119: 727–730

    CAS  PubMed  Google Scholar 

  2. ATS/ERS/WASOG Committee (1999) Statement on Sarcoidosis. Am J Respir Crit Care Med 160: 736–755

  3. Alazemi S and Campos MA (2006) Interferon-induced sarcoidosis. Int J Clin Pract 60: 201–211

    Article  CAS  Google Scholar 

  4. Pietropaoli A et al. (1999) Interferon-alpha therapy associated with the development of sarcoidosis. Chest 116: 569–572

    Article  CAS  Google Scholar 

  5. Teragawa H et al. (1996) Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 35: 19–23

    Article  CAS  Google Scholar 

  6. Tahan V et al. (2003) Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Dig Dis Sci 48: 169–173

    Article  CAS  Google Scholar 

  7. Goldberg HJ et al. (2006) Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 100: 2063–2068

    Article  Google Scholar 

  8. Hoffmann RM et al. (1998) Sarcoidosis associated with interferon-(alpha) therapy for chronic hepatitis C. J Hepatol 28: 1058–1063

    Article  CAS  Google Scholar 

  9. Bonnet F et al. (2002) Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci 47: 794–796

    Article  CAS  Google Scholar 

  10. Johns CJ and Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine 78: 65–111

    Article  CAS  Google Scholar 

  11. Harry LI (1994) Sarcoidosis lymphadenopathy. I. Lymph node pathology, edn 2, Chapter 30 206–216 Philadelphia: JB Lippincott Company

    Google Scholar 

  12. Furin JJ and Johnson JL (2005) Recent advances in the diagnosis and management of tuberculosis. Curr Opin Pulm Med 11: 189–194

    PubMed  Google Scholar 

  13. Jha BC et al. (2001) Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J 77: 185–187

    Article  CAS  Google Scholar 

  14. Portuguese National Program against Tuberculosis (2005) [Portuguese] [http://www.dgsaude.pt/upload/membro.id/ficheiros/i006875.pdf] (accessed 5 May 2008)

  15. American Thoracic Society; Centers for Disease Control and Prevention; and Infectious Diseases Society of America (2003) Treatment of Tuberculosis. Am J Respir Crit Care Med 167: 603–662

Download references

Acknowledgements

We would like to thank Professor R Marinho and Dr C Baldaia for their helpful suggestions during the drafting of the article and also for their words of encouragement.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos Noronha Ferreira.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferreira, C., Barjas, E., Correia, L. et al. Generalized peripheral lymphadenopathy in a patient treated for chronic HCV infection. Nat Rev Gastroenterol Hepatol 5, 469–474 (2008). https://doi.org/10.1038/ncpgasthep1176

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep1176

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing